Boston Scientific's total assets for Q4 2024 were $39.40B, an increase of 3.46% from the previous quarter. BSX total liabilities were $17.39B for the fiscal quarter, a 1.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.